PO-333 Molecular heterogenity in neuroblastoma (on behalf of turkish paediatric oncology group)
Sign Up to like & getrecommendations! Published in 2018 at "ESMO Open"
DOI: 10.1136/esmoopen-2018-eacr25.845
Abstract: Introduction Heterogeneity in cancer is the difference of tumour cells in biological behaviours. Neuroblastoma treatment depends on risk classification including molecular tests. In this study, we searched for heterogeneity in DNA ploidy, MYCN amplification, 1pLOH,… read more here.
Keywords: heterogeneity; group; paediatric oncology; turkish paediatric ... See more keywords